Biomedicine & Pharmacotherapy Pharmacology

Identification of TAS2R-targeting bioactive compounds against metabolic decline: A novel ex vivo methodology based on enteroendocrine and inflammatory readouts

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →